Patent details

300961 Product Name: Erenumab

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
300961
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2379594
Status:
SPC granted but not yet in force
Application number:
300961
Procedural language:
Dutch
First Applicant Residence Country:
United States of America (US)

Marketing Authorization

Marketing Authorization Number:
EU/1/18/1293
Marketing Authorization Type:
EEA
Marketing Authorization Date:
30/07/2018
Marketing Authorization Country:
European Union (EU)

Dates

Filing date:
12/12/2018
First Marketing Authorization date:
30/07/2018
Grant date:
15/01/2019
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
13/12/2018
SPC/SPC Extension Expiration Date:
29/07/2033
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
12/12/2018
 
 

 

Name:
Amgen Inc.
Address:
One Amgen Center Drive, THOUSAND OAKS, CA 91320-1799, United States of America (US)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
12/12/2018
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

1

Bulletin Heading:
SPC
Journal edition number:
03/19
Publication date:
16/01/2019
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

2

Bulletin Heading:
SPC
Journal edition number:
52/18
Publication date:
19/12/2018
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)

Annual Fee

Annual Fee(s) Due Date:
31/12/2029
Annual Fee Number:
21
Annual Fee Amount:
1600 Euro
Last Annual Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Document Description Number of pages File Type
29/01/2019 Outgoing Correspondence Letter to applicant 1 PDF /9/5/5/2/5/0800352559/docs/300961_1_outgoingcorrespondence20190130110449708.pdf
29/01/2019 SPC Documents Certificate SPC 1 PDF /9/5/5/2/5/0800352559/docs/300961_4_supplprotectioncertificate20190130110449771.pdf
24/01/2019 Incoming Correspondence Paper Incoming Correspondence Paper 1 PDF /9/5/5/2/5/0800352559/docs/300961_2_incomingcorrespondencepaper20190128111501551.pdf
15/01/2019 SPC Documents Certificate SPC 1 PDF /9/5/5/2/5/0800352559/docs/300961_3_supplprotectioncertificate20190116024201517.pdf
15/01/2019 Outgoing Correspondence Decision grant 1 PDF /9/5/5/2/5/0800352559/docs/300961_12_outgoingcorrespondence20190116024201397.pdf
13/12/2018 Outgoing Correspondence Confirmation receipt request 1 PDF /9/5/5/2/5/0800352559/docs/300961_8_245079l174.pdf
12/12/2018 SPC Documents Marketing Authorization SPC 3 PDF /9/5/5/2/5/0800352559/docs/300961_0_supplprotectioncertificate20181213020941831.pdf
12/12/2018 SPC Documents SPC Documents 15 PDF /9/5/5/2/5/0800352559/docs/300961_5_supplprotectioncertificate20181213033337529.pdf
12/12/2018 SPC Documents Annex SPC 3 PDF /9/5/5/2/5/0800352559/docs/300961_6_supplprotectioncertificate20181213020941625.pdf
12/12/2018 SPC Documents Annex SPC 4 PDF /9/5/5/2/5/0800352559/docs/300961_7_supplprotectioncertificate20210115044811558.pdf
12/12/2018 Application Form First filed application form 2 PDF /9/5/5/2/5/0800352559/docs/300961_9_applicationform20181213020941116.pdf
12/12/2018 SPC Documents Annex SPC 34 PDF /9/5/5/2/5/0800352559/docs/300961_10_supplprotectioncertificate20181213020941729.pdf
12/12/2018 SPC Documents Annex SPC 14 PDF /9/5/5/2/5/0800352559/docs/300961_11_supplprotectioncertificate20210115044032212.pdf